- Home
- AMZN vs ABT Comparison
AMZN vs ABT Comparison
Compare AMZN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMZN | ABT |
|---|---|---|
| Founded | 1994 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1T | 152.9B |
| IPO Year | 1997 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AMZN | ABT |
|---|---|---|
| Price | $243.55 | $91.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 42 | 20 |
| Target Price | ★ $285.88 | $130.90 |
| AVG Volume (30 Days) | ★ 31.4M | 9.5M |
| Earning Date | 04-29-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ 29.66 | N/A |
| EPS | ★ 2.78 | 0.61 |
| Revenue | ★ $716,924,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | $14.63 | $10.75 |
| Revenue Next Year | $11.81 | $8.10 |
| P/E Ratio | ★ $88.22 | $148.57 |
| Revenue Growth | ★ 12.38 | 5.67 |
| 52 Week Low | $196.00 | $81.97 |
| 52 Week High | $278.56 | $137.49 |
Technical Indicators
Market Signals| Indicator | AMZN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 36.36 | 57.42 |
| Support Level | $216.95 | $84.96 |
| Resistance Level | $248.36 | $103.84 |
| Average True Range (ATR) | 7.13 | 1.67 |
| MACD | -3.73 | 1.01 |
| Stochastic Oscillator | 16.93 | 82.95 |
Price Performance
Historical ComparisonAbout AMZN Amazon.com Inc.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.